{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T19:13:02Z","timestamp":1776366782236,"version":"3.51.2"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Scientific Research Program of FuRong Laboratory","award":["No.2024PT5109"],"award-info":[{"award-number":["No.2024PT5109"]}]},{"name":"the National Key R&D Program of China","award":["2021YFA0805202"],"award-info":[{"award-number":["2021YFA0805202"]}]},{"name":"Science and Technology Innovation 2030","award":["STI2030-Major Projects: 2021ZD0201803"],"award-info":[{"award-number":["STI2030-Major Projects: 2021ZD0201803"]}]},{"name":"Project Program of National Clinical Research Center for Geriatric Disorders","award":["Xiangya Hospital, Grant No. 2020LNJJ13 and 2022LNJJ09"],"award-info":[{"award-number":["Xiangya Hospital, Grant No. 2020LNJJ13 and 2022LNJJ09"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 62402176"],"award-info":[{"award-number":["No. 62402176"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["2024JJ6191"],"award-info":[{"award-number":["2024JJ6191"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Changsha Municipal Natural Science Foundation","award":["kq2402099"],"award-info":[{"award-number":["kq2402099"]}]},{"name":"Project Supported by Scientific Research Fund of Hunan Provincial Education Department","award":["23B0626"],"award-info":[{"award-number":["23B0626"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00259-025-07585-5","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:46:21Z","timestamp":1759484781000},"page":"2018-2033","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Brain metabolic imaging with 18\u00a0F-PET-CT and machine-learning clustering analysis reveal divergent metabolic phenotypes in patients with amyotrophic lateral sclerosis"],"prefix":"10.1007","volume":"53","author":[{"given":"Jinfan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuchang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Grecucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bihong T.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"6","key":"7585_CR1","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1212\/WNL.0000000000207474","volume":"101","author":"C Wolfson","year":"2023","unstructured":"Wolfson C, Gauvin DE, Ishola F, et al. Global prevalence and incidence of amyotrophic lateral sclerosis: a systematic review. Neurology. 2023;101(6):e613\u201323. https:\/\/doi.org\/10.1212\/WNL.0000000000207474.","journal-title":"Neurology"},{"issue":"11","key":"7585_CR2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jamaneurol.2019.2044","volume":"76","author":"M Ryan","year":"2019","unstructured":"Ryan M, Heverin M, McLaughlin RL, et al. Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol. 2019;76(11):1367\u201374. https:\/\/doi.org\/10.1001\/jamaneurol.2019.2044.","journal-title":"JAMA Neurol"},{"issue":"10360","key":"7585_CR3","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S, et al. Amyotrophic lateral sclerosis. Lancet. 2022;400(10360):1363\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(22)01272-7.","journal-title":"Lancet"},{"issue":"5","key":"7585_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/wco.0000000000000730","volume":"32","author":"E Longinetti","year":"2019","unstructured":"Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32(5):771\u20136. https:\/\/doi.org\/10.1097\/wco.0000000000000730.","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"7585_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"Collaborators GBDN","year":"2019","unstructured":"Collaborators GBDN. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459\u201380. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X.","journal-title":"Lancet Neurol"},{"issue":"11","key":"7585_CR6","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3390\/cells12111523","volume":"12","author":"L Tzeplaeff","year":"2023","unstructured":"Tzeplaeff L, Wilfling S, Requardt MV, et al. Current state and future directions in the therapy of ALS. Cells. 2023;12(11):1523. https:\/\/doi.org\/10.3390\/cells12111523.","journal-title":"Cells"},{"key":"7585_CR7","doi-asserted-by":"publisher","first-page":"e075037","DOI":"10.1136\/bmj-2023-075037","volume":"383","author":"H Ilieva","year":"2023","unstructured":"Ilieva H, Vullaganti M, Kwan J. Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis. BMJ. 2023;383:e075037. https:\/\/doi.org\/10.1136\/bmj-2023-075037.","journal-title":"BMJ"},{"issue":"5","key":"7585_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/cells13050452","volume":"13","author":"L Tzeplaeff","year":"2024","unstructured":"Tzeplaeff L, J\u00fcrs AV, Wohnrade C, et al. Unraveling the heterogeneity of ALS-a call to redefine patient stratification for better outcomes in clinical trials. Cells. 2024;13(5):452. https:\/\/doi.org\/10.3390\/cells13050452.","journal-title":"Cells"},{"issue":"12","key":"7585_CR9","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S1474-4422(14)70167-X","volume":"13","author":"A Chi\u00f2","year":"2014","unstructured":"Chi\u00f2 A, Pagani M, Agosta F, et al. Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. Lancet Neurol. 2014;13(12):1228\u201340. https:\/\/doi.org\/10.1016\/S1474-4422(14)70167-X.","journal-title":"Lancet Neurol"},{"issue":"1","key":"7585_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/biom15010081","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, Zhang Z, Wang Y. Utilizing feature selection techniques for AI-driven tumor subtype classification: enhancing precision in cancer diagnostics. Biomolecules. 2025;15(1):81. https:\/\/doi.org\/10.3390\/biom15010081.","journal-title":"Biomolecules"},{"issue":"2","key":"7585_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14020462","volume":"14","author":"A Bednarek","year":"2025","unstructured":"Bednarek A, Gumi\u0119\u017cna K, Baru\u015b P, et al. Artificial intelligence in imaging for personalized management of coronary artery disease. J Clin Med. 2025;14(2):462. https:\/\/doi.org\/10.3390\/jcm14020462.","journal-title":"J Clin Med"},{"issue":"3","key":"7585_CR12","doi-asserted-by":"publisher","DOI":"10.31083\/j.jin2303058","volume":"23","author":"EL Tan","year":"2024","unstructured":"Tan EL, Lope J, Bede P. Harnessing big data in amyotrophic lateral sclerosis: machine learning applications for clinical practice and pharmaceutical trials. J Integr Neurosci. 2024;23(3):58. https:\/\/doi.org\/10.31083\/j.jin2303058.","journal-title":"J Integr Neurosci"},{"key":"7585_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2023.122585","volume":"240","author":"B Tafuri","year":"2024","unstructured":"Tafuri B, Milella G, Filardi M, et al. Machine learning-based radiomics for amyotrophic lateral sclerosis diagnosis. Expert Syst Appl. 2024;240:122585. https:\/\/doi.org\/10.1016\/j.eswa.2023.122585.","journal-title":"Expert Syst Appl"},{"issue":"6","key":"7585_CR14","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/ana.26488","volume":"92","author":"HHG Tan","year":"2022","unstructured":"Tan HHG, Westeneng H-J, Nitert AD, et al. MRI clustering reveals three ALS subtypes with unique neurodegeneration patterns. Ann Neurol. 2022;92(6):1030\u201345. https:\/\/doi.org\/10.1002\/ana.26488.","journal-title":"Ann Neurol"},{"key":"7585_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.103094","volume":"35","author":"A Behler","year":"2022","unstructured":"Behler A, M\u00fcller H-P, Ludolph AC, et al. A multivariate bayesian classification algorithm for cerebral stage prediction by diffusion tensor imaging in amyotrophic lateral sclerosis. NeuroImage: Clinical. 2022;35:103094. https:\/\/doi.org\/10.1016\/j.nicl.2022.103094.","journal-title":"NeuroImage: Clinical"},{"key":"7585_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.nicl.2016.10.008","volume":"13","author":"HK van der Burgh","year":"2016","unstructured":"van der Burgh HK, Schmidt R, Westeneng H-J, et al. Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis. Neuroimage Clin. 2016;13:361\u20139. https:\/\/doi.org\/10.1016\/j.nicl.2016.10.008.","journal-title":"Neuroimage Clin"},{"issue":"1","key":"7585_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12883-017-0854-x","volume":"17","author":"C Schuster","year":"2017","unstructured":"Schuster C, Hardiman O, Bede P. Survival prediction in amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. BMC Neurol. 2017;17(1):73. https:\/\/doi.org\/10.1186\/s12883-017-0854-x.","journal-title":"BMC Neurol"},{"issue":"12","key":"7585_CR18","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.3390\/biomedicines9121944","volume":"9","author":"K-H Chang","year":"2021","unstructured":"Chang K-H, Lin C-N, Chen C-M, et al. Altered metabolic profiles of the plasma of patients with amyotrophic lateral sclerosis. Biomedicines. 2021;9(12):1944. https:\/\/doi.org\/10.3390\/biomedicines9121944.","journal-title":"Biomedicines"},{"issue":"11","key":"7585_CR19","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1007\/s00259-020-04786-y","volume":"47","author":"D Van Weehaeghe","year":"2020","unstructured":"Van Weehaeghe D, Devrome M, Schramm G, et al. Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics. Eur J Nucl Med Mol Imaging. 2020;47(11):2681\u201390. https:\/\/doi.org\/10.1007\/s00259-020-04786-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"7585_CR20","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.2967\/jnumed.115.166272","volume":"57","author":"D Van Weehaeghe","year":"2016","unstructured":"Van Weehaeghe D, Ceccarini J, Delva A, et al. Prospective validation of 18F-FDG brain PET discriminant analysis methods in the diagnosis of amyotrophic lateral sclerosis. J Nucl Med. 2016;57(8):1238\u201343. https:\/\/doi.org\/10.2967\/jnumed.115.166272.","journal-title":"J Nucl Med"},{"issue":"5","key":"7585_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae222","volume":"6","author":"F Feng","year":"2024","unstructured":"Feng F, Feng G, Liu J, et al. Different patterns of structural network impairments in two amyotrophic lateral sclerosis subtypes driven by 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance hybrid imaging. Brain Commun. 2024;6(5):fcae222. https:\/\/doi.org\/10.1093\/braincomms\/fcae222.","journal-title":"Brain Commun"},{"issue":"5\u20136","key":"7585_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/21678421.2023.2174881","volume":"24","author":"S Sennf\u00e4lt","year":"2023","unstructured":"Sennf\u00e4lt S, Pagani M, Fang F, et al. FDG-PET shows weak correlation between focal motor weakness and brain metabolic alterations in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2023;24(5\u20136):485\u201394. https:\/\/doi.org\/10.1080\/21678421.2023.2174881.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"6","key":"7585_CR23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3390\/cells12060933","volume":"12","author":"J De Vocht","year":"2023","unstructured":"De Vocht J, Van Weehaeghe D, Ombelet F, et al. Differences in cerebral glucose metabolism in ALS patients with and without C9orf72 and SOD1 mutations. Cells. 2023;12(6):933. https:\/\/doi.org\/10.3390\/cells12060933.","journal-title":"Cells"},{"issue":"1","key":"7585_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1109\/TKDE.2014.2316512","volume":"27","author":"J Wu","year":"2015","unstructured":"Wu J, Liu H, Xiong H, et al. K-means-based consensus clustering: a unified view. IEEE Trans Knowl Data Eng. 2015;27(1):155\u201369. https:\/\/doi.org\/10.1109\/TKDE.2014.2316512.","journal-title":"IEEE Trans Knowl Data Eng"},{"issue":"8","key":"7585_CR25","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","volume":"131","author":"JM Shefner","year":"2020","unstructured":"Shefner JM, Al-Chalabi A, Baker MR, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 2020;131(8):1975\u20138. https:\/\/doi.org\/10.1016\/j.clinph.2020.04.005.","journal-title":"Clin Neurophysiol"},{"issue":"1\u20132","key":"7585_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s0022-510x(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (Phase III). J Neurol Sci. 1999;169(1\u20132):13\u201321.https:\/\/doi.org\/10.1016\/s0022-510x(99)00210-5.","journal-title":"J Neurol Sci"},{"issue":"2","key":"7585_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","volume":"66","author":"F Kimura","year":"2006","unstructured":"Kimura F, Fujimura C, Ishida S, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66(2):265\u20137. https:\/\/doi.org\/10.1212\/01.wnl.0000194316.91908.8a.","journal-title":"Neurology"},{"issue":"3\u20134","key":"7585_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/21678421.2014.897357","volume":"15","author":"R Balendra","year":"2014","unstructured":"Balendra R, Jones A, Jivraj N, et al. Estimating clinical stage of amyotrophic lateral sclerosis from the AL s functional rating scale. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(3\u20134):279\u201384. https:\/\/doi.org\/10.3109\/21678421.2014.897357.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"3","key":"7585_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiatr Res"},{"issue":"9","key":"7585_CR30","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"7585_CR31","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137. https:\/\/doi.org\/10.1001\/archinte.166.10.1092.","journal-title":"Arch Intern Med"},{"key":"7585_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v061.i06","volume":"61","author":"M Charrad","year":"2014","unstructured":"Charrad M, Ghazzali N, Boiteau V, et al. NbClust: an R package for determining the relevant number of clusters in a data set. J Stat Softw. 2014;61:1\u201336. https:\/\/doi.org\/10.18637\/jss.v061.i06.","journal-title":"J Stat Softw"},{"issue":"9","key":"7585_CR33","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nrneurol.2012.148","volume":"8","author":"J-N Foo","year":"2012","unstructured":"Foo J-N, Liu J-J, Tan E-K. Whole-genome and whole-exome sequencing in neurological diseases. Nat Rev Neurol. 2012;8(9):508\u201317. https:\/\/doi.org\/10.1038\/nrneurol.2012.148.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"7585_CR34","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1007\/s00415-024-12201-x","volume":"271","author":"W Sun","year":"2024","unstructured":"Sun W, Liu S-H, Wei X-J, et al. Potential of neuroimaging as a biomarker in amyotrophic lateral sclerosis: from structure to metabolism. J Neurol. 2024;271(5):2238\u201357. https:\/\/doi.org\/10.1007\/s00415-024-12201-x.","journal-title":"J Neurol"},{"issue":"5","key":"7585_CR35","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1021\/acschemneuro.0c00772","volume":"12","author":"MM Makary","year":"2021","unstructured":"Makary MM, Weerasekara A, Rodham H, et al. Comparison of two clinical upper motor neuron burden rating scales in ALS using quantitative brain imaging. ACS Chem Neurosci. 2021;12(5):906\u201316. https:\/\/doi.org\/10.1021\/acschemneuro.0c00772.","journal-title":"ACS Chem Neurosci"},{"key":"7585_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.103222","volume":"36","author":"G Tondo","year":"2022","unstructured":"Tondo G, Mazzini L, Caminiti SP, et al. Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers. NeuroImage: Clinical. 2022;36:103222. https:\/\/doi.org\/10.1016\/j.nicl.2022.103222.","journal-title":"NeuroImage: Clinical"},{"issue":"1","key":"7585_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/A:1023949509487","volume":"52","author":"S Monti","year":"2003","unstructured":"Monti S, Tamayo P, Mesirov J, et al. Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach Learn. 2003;52(1):91\u2013118. https:\/\/doi.org\/10.1023\/A:1023949509487.","journal-title":"Mach Learn"},{"key":"7585_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbaf037","author":"L Wei","year":"2025","unstructured":"Wei L, Liu W, Li X, et al. Deciphering the heterogeneity of schizophrenia: A multimodal and multivariate neuroimaging framework for unveiling Brain-Symptom relationships and underlying subtypes. Schizophr Bull. 2025. https:\/\/doi.org\/10.1093\/schbul\/sbaf037.","journal-title":"Schizophr Bull"},{"issue":"8","key":"7585_CR39","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/rlu.0000000000003668","volume":"46","author":"K Zukotynski","year":"2021","unstructured":"Zukotynski K, Black SE, Kuo PH, et al. Exploratory assessment of K-means clustering to classify 18F-flutemetamol brain PET as positive or negative. Clin Nucl Med. 2021;46(8):616\u201320. https:\/\/doi.org\/10.1097\/rlu.0000000000003668.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"7585_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/widm.1174","volume":"6","author":"A Derntl","year":"2016","unstructured":"Derntl A, Plant C. Clustering techniques for neuroimaging applications. Wiley Interdiscip Rev Data Min Knowl Discov. 2016;6(1):22\u201336. https:\/\/doi.org\/10.1002\/widm.1174.","journal-title":"Wiley Interdiscip Rev Data Min Knowl Discov"},{"issue":"9","key":"7585_CR41","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1007\/s00429-019-01945-2","volume":"224","author":"ET Rolls","year":"2019","unstructured":"Rolls ET. The cingulate cortex and limbic systems for emotion, action, and memory. Brain Struct Funct. 2019;224(9):3001\u201318. https:\/\/doi.org\/10.1007\/s00429-019-01945-2.","journal-title":"Brain Struct Funct"},{"issue":"8","key":"7585_CR42","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1093\/brain\/awy152","volume":"141","author":"C Marini","year":"2018","unstructured":"Marini C, Morbelli S, Cistaro A, et al. Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis. Brain. 2018;141(8):2272\u20139. https:\/\/doi.org\/10.1093\/brain\/awy152.","journal-title":"Brain"},{"issue":"2","key":"7585_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00259-011-1979-6","volume":"39","author":"A Cistaro","year":"2012","unstructured":"Cistaro A, Valentini MC, Chi\u00f2 A, et al. Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging. 2012;39(2):251\u20139. https:\/\/doi.org\/10.1007\/s00259-011-1979-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"7585_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1212\/WNL.0000000000002242","volume":"86","author":"A Canosa","year":"2016","unstructured":"Canosa A, Pagani M, Cistaro A, et al. 18F-FDG-PET correlates of cognitive impairment in ALS. Neurology. 2016;86(1):44\u20139.","journal-title":"Neurology"},{"issue":"9","key":"7585_CR45","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1111\/cns.14193","volume":"29","author":"P Liu","year":"2023","unstructured":"Liu P, Tang Y, Li W, et al. Brain metabolic signatures in patients with genetic and nongenetic amyotrophic lateral sclerosis. CNS Neurosci Ther. 2023;29(9):2530\u20139. https:\/\/doi.org\/10.1111\/cns.14193.","journal-title":"CNS Neurosci Ther"},{"issue":"10","key":"7585_CR46","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1111\/ene.14332","volume":"27","author":"V Rajagopalan","year":"2020","unstructured":"Rajagopalan V, Pioro E. 2\u2010Deoxy\u20102\u2010[18F]fluoro\u2010d\u2010glucose positron emission tomography, cortical thickness and white matter graph network abnormalities in brains of patients with amyotrophic lateral sclerosis and frontotemporal dementia suggest early neuronopathy rather than axonopathy. Eur J Neurol. 2020;27(10):1904\u201312. https:\/\/doi.org\/10.1111\/ene.14332.","journal-title":"Eur J Neurol"},{"key":"7585_CR47","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00259-018-4246-2","volume":"46","author":"A Sala","year":"2019","unstructured":"Sala A, Iaccarino L, Fania P, et al. Testing the diagnostic accuracy of [18F] FDG-PET in discriminating spinal-and bulbar-onset amyotrophic lateral sclerosis. Eur J Nucl Med Mol Imaging. 2019;46:1117\u201331. https:\/\/doi.org\/10.1007\/s00259-018-4246-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"7585_CR48","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s00259-020-05053-w","volume":"48","author":"A Canosa","year":"2021","unstructured":"Canosa A, Calvo A, Moglia C, et al. Brain metabolic changes across king\u2019s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-D-glucose-positron emission tomography study. Eur J Nucl Med Mol Imaging. 2021;48(4):1124\u201333. https:\/\/doi.org\/10.1007\/s00259-020-05053-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7585_CR49","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00415-015-7731-6","volume":"262","author":"M Elamin","year":"2015","unstructured":"Elamin M, Bede P, Montuschi A, et al. Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm. J Neurol. 2015;262:1447\u201354. https:\/\/doi.org\/10.1007\/s00415-015-7731-6.","journal-title":"J Neurol"},{"issue":"2","key":"7585_CR50","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.chest.2018.06.035","volume":"155","author":"S Niedermeyer","year":"2019","unstructured":"Niedermeyer S, Murn M, Choi PJ. Respiratory failure in amyotrophic lateral sclerosis. Chest. 2019;155(2):401\u20138. https:\/\/doi.org\/10.1016\/j.chest.2018.06.035.","journal-title":"Chest"},{"key":"7585_CR51","doi-asserted-by":"publisher","unstructured":"Jellinger KA. Mild cognitive impairment in amyotrophic lateral sclerosis: current view. J Neural Transm. 2024:1\u201312 https:\/\/doi.org\/10.1007\/s00702-024-02850-7","DOI":"10.1007\/s00702-024-02850-7"},{"issue":"4","key":"7585_CR52","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1017\/s104161020700542x","volume":"19","author":"BS Diniz","year":"2007","unstructured":"Diniz BS, Yassuda MS, Nunes PV, et al. Mini-mental state examination performance in mild cognitive impairment subtypes. Int Psychogeriatr. 2007;19(4):647\u201356. https:\/\/doi.org\/10.1017\/s104161020700542x.","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"7585_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jpsychires.2008.04.014","volume":"43","author":"AJ Mitchell","year":"2009","unstructured":"Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res. 2009;43(4):411\u201331. https:\/\/doi.org\/10.1016\/j.jpsychires.2008.04.014.","journal-title":"J Psychiatr Res"},{"issue":"6","key":"7585_CR54","doi-asserted-by":"publisher","first-page":"e0304593","DOI":"10.1371\/journal.pone.0304593","volume":"19","author":"A Serian","year":"2024","unstructured":"Serian A, Finsel J, Ludolph AC, et al. Screening instruments of cognition: the relation of the mini-mental state examination to the Edinburgh cognitive and behavioural ALS screen in amyotrophic lateral sclerosis. PLoS ONE. 2024;19(6):e0304593. https:\/\/doi.org\/10.1371\/journal.pone.0304593.","journal-title":"PLoS ONE"},{"issue":"6","key":"7585_CR55","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/jnnp-2015-310734","volume":"87","author":"E Beeldman","year":"2016","unstructured":"Beeldman E, Raaphorst J, Twennaar MK, et al. The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry. 2016;87(6):611\u20139. https:\/\/doi.org\/10.1136\/jnnp-2015-310734.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"7585_CR56","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/s1474-4422(13)70026-7","volume":"12","author":"LH Goldstein","year":"2013","unstructured":"Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12(4):368\u201380. https:\/\/doi.org\/10.1016\/s1474-4422(13)70026-7.","journal-title":"Lancet Neurol"},{"key":"7585_CR57","doi-asserted-by":"publisher","first-page":"1322118","DOI":"10.3389\/fpsyt.2024.1322118","volume":"15","author":"SB Singh","year":"2024","unstructured":"Singh SB, Tiwari A, Katta MR, et al. The utility of PET imaging in depression. Front Psychiatry. 2024;15:1322118. https:\/\/doi.org\/10.3389\/fpsyt.2024.1322118.","journal-title":"Front Psychiatry"},{"key":"7585_CR58","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neulet.2017.05.062","volume":"653","author":"X Wang","year":"2017","unstructured":"Wang X, Zhang J, Yuan Y, et al. Cerebral metabolic change in Parkinson\u2019s disease patients with anxiety: a FDG-PET study. Neurosci Lett. 2017;653:202\u20137. https:\/\/doi.org\/10.1016\/j.neulet.2017.05.062.","journal-title":"Neurosci Lett"},{"issue":"4","key":"7585_CR59","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1136\/jmedgenet-2011-100699","volume":"49","author":"S Millecamps","year":"2012","unstructured":"Millecamps S, Boill\u00e9e S, Le Ber I, et al. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J Med Genet. 2012;49(4):258\u201363. https:\/\/doi.org\/10.1136\/jmedgenet-2011-100699.","journal-title":"J Med Genet"},{"issue":"5","key":"7585_CR60","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/WCO.0000000000001294","volume":"37","author":"M Nijs","year":"2024","unstructured":"Nijs M, Van Damme P. The genetics of amyotrophic lateral sclerosis. Curr Opin Neurol. 2024;37(5):560\u20139. https:\/\/doi.org\/10.1097\/WCO.0000000000001294.","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"7585_CR61","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/s1474-4422(24)00517-9","volume":"24","author":"TG Moens","year":"2025","unstructured":"Moens TG, Da Cruz S, Neumann M, et al. Amyotrophic lateral sclerosis caused by FUS mutations: advances with broad implications. Lancet Neurol. 2025;24(2):166\u201378. https:\/\/doi.org\/10.1016\/s1474-4422(24)00517-9.","journal-title":"Lancet Neurol"},{"issue":"5","key":"7585_CR62","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/cge.12117","volume":"83","author":"M Sabatelli","year":"2013","unstructured":"Sabatelli M, Conte A, Zollino M. Clinical and genetic heterogeneity of amyotrophic lateral sclerosis. Clin Genet. 2013;83(5):408\u201316. https:\/\/doi.org\/10.1111\/cge.12117.","journal-title":"Clin Genet"},{"issue":"3","key":"7585_CR63","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","volume":"22","author":"RJ Mead","year":"2023","unstructured":"Mead RJ, Shan N, Reiser HJ, et al. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov. 2023;22(3):185\u2013212. https:\/\/doi.org\/10.1038\/s41573-022-00612-2.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"7585_CR64","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1007\/s00415-024-12485-z","volume":"271","author":"H Wang","year":"2024","unstructured":"Wang H, Zeng R. Aberrant protein aggregation in amyotrophic lateral sclerosis. J Neurol. 2024;271(8):4826\u201351. https:\/\/doi.org\/10.1007\/s00415-024-12485-z.","journal-title":"J Neurol"},{"issue":"1","key":"7585_CR65","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1038\/s41467-024-47758-8","volume":"15","author":"S Tsitkov","year":"2024","unstructured":"Tsitkov S, Valentine K, Kozareva V, et al. Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls. Nat Commun. 2024;15(1):3606. https:\/\/doi.org\/10.1038\/s41467-024-47758-8.","journal-title":"Nat Commun"},{"key":"7585_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115295","volume":"206","author":"L Zhang","year":"2022","unstructured":"Zhang L, Liu Y, Lu Y, et al. Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases. Biochem Pharmacol. 2022;206:115295. https:\/\/doi.org\/10.1016\/j.bcp.2022.115295.","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"7585_CR67","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.bbadis.2018.10.019","volume":"1865","author":"SN Cobos","year":"2019","unstructured":"Cobos SN, Bennett SA, Torrente MP. The impact of histone post-translational modifications in neurodegenerative diseases. Biochimica et Biophysica Acta (BBA). 2019;1865(8):1982\u201391. https:\/\/doi.org\/10.1016\/j.bbadis.2018.10.019.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"6","key":"7585_CR68","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/bph.15217","volume":"178","author":"YE Klingl","year":"2021","unstructured":"Klingl YE, Pakravan D, Van Den Bosch L. Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis. Br J Pharmacol. 2021;178(6):1353\u201372. https:\/\/doi.org\/10.1111\/bph.15217.","journal-title":"Br J Pharmacol"},{"key":"7585_CR69","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fncel.2019.00063","volume":"13","author":"CM Henstridge","year":"2019","unstructured":"Henstridge CM, Tzioras M, Paolicelli RC. Glial contribution to excitatory and inhibitory synapse loss in neurodegeneration. Front Cell Neurosci. 2019;13:63. https:\/\/doi.org\/10.3389\/fncel.2019.00063.","journal-title":"Front Cell Neurosci"},{"key":"7585_CR70","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fneur.2019.00135","volume":"10","author":"S Chew","year":"2019","unstructured":"Chew S, Atassi N. Positron emission tomography molecular imaging biomarkers for amyotrophic lateral sclerosis. Front Neurol. 2019;10:135. https:\/\/doi.org\/10.3389\/fneur.2019.00135.","journal-title":"Front Neurol"},{"issue":"6","key":"7585_CR71","doi-asserted-by":"publisher","first-page":"e39216","DOI":"10.1371\/journal.pone.0039216","volume":"7","author":"J Brettschneider","year":"2012","unstructured":"Brettschneider J, Toledo JB, Van Deerlin VM, et al. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS ONE. 2012;7(6):e39216. https:\/\/doi.org\/10.1371\/journal.pone.0039216.","journal-title":"PLoS ONE"},{"issue":"4","key":"7585_CR72","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/glia.20210","volume":"51","author":"SA Sargsyan","year":"2005","unstructured":"Sargsyan SA, Monk PN, Shaw PJ. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia. 2005;51(4):241\u201353. https:\/\/doi.org\/10.1002\/glia.20210.","journal-title":"Glia"},{"issue":"4","key":"7585_CR73","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/jnnp-2019-321916","volume":"91","author":"L Vu","year":"2020","unstructured":"Vu L, An J, Kovalik T, et al. Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astro cytes. J Neurol Neurosurg Psychiatry. 2020;91(4):350\u20138. https:\/\/doi.org\/10.1136\/jnnp-2019-321916.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"7585_CR74","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","volume":"183","author":"C-H Yu","year":"2020","unstructured":"Yu C-H, Davidson S, Harapas CR, et al. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS. Cell. 2020;183(3):636\u201349. https:\/\/doi.org\/10.1016\/j.cell.2020.09.020. e18.","journal-title":"Cell"},{"issue":"7713","key":"7585_CR75","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","volume":"559","author":"SM Haag","year":"2018","unstructured":"Haag SM, Gulen MF, Reymond L, et al. Targeting STING with covalent small-molecule inhibitors. Nature. 2018;559(7713):269\u201373. https:\/\/doi.org\/10.1038\/s41586-018-0287-8.","journal-title":"Nature"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07585-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07585-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07585-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:42:58Z","timestamp":1769834578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07585-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7585"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07585-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"3 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Ethics Committee and Institutional Review Board of Xiangya hospital, Central South University (IRB No. 202103191).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}